Suppr超能文献

当药物使薄膜包衣增塑时:观察到美托洛尔和 Eudragit RS 的不同寻常的制剂效应。

When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS.

机构信息

Univ. Lille, Inserm, CHU Lille, U1008, F-59000 Lille, France.

Univ. Lille, USTL UMET UMR CNRS 8207, F-59650 Villeneuve d'Ascq, France.

出版信息

Int J Pharm. 2018 Mar 25;539(1-2):39-49. doi: 10.1016/j.ijpharm.2018.01.014. Epub 2018 Jan 11.

Abstract

Metoprolol tartrate and metoprolol free base loaded pellet starter cores were coated with Eudragit RS, plasticized with 25% triethyl citrate (TEC). The initial drug loading and coating level were varied from 10 to 40 and 0 to 20%, respectively. Drug release was measured in 0.1 N HCl and phosphate buffer pH 7.4. The water uptake and swelling kinetics, mechanical properties and TEC leaching of/from coated pellets and/or thin, free films of identical composition as the film coatings were monitored. The following unusual tendencies were observed: (i) the relative drug release rate from coated pellets increased with increasing initial drug content, and (ii) drug release from pellets was much faster for metoprolol free base compared to metoprolol tartrate, despite its much lower solubility (factor >70). These phenomena could be explained by plasticizing effects of the drug for the polymeric film coatings. In particular: 1) Metoprolol free base is a much more potent plasticizer for Eudragit RS than the tartrate, leading to higher film permeability and overcompensating the pronounced differences in drug solubility. Also, Raman imaging revealed that substantial amounts of the free base migrated into the film coatings, whereas this was not the case for the tartrate. 2) The plasticizing effects of the drug for the film coating overcompensated potential increasing limited solubility effects when increasing the initial drug loading from 10 to 40%. In summary, this study clearly demonstrates how important the plasticization of polymeric controlled release film coatings by drugs can be, leading to unexpected formulation effects.

摘要

酒石酸美托洛尔和游离碱美托洛尔载药丸芯先用 Eudragit RS 包衣,再用 25%柠檬酸三乙酯(TEC)增塑。初始载药量和包衣量分别在 10%到 40%和 0%到 20%之间变化。在 0.1N HCl 和磷酸盐缓冲液 pH 7.4 中测量药物释放。监测了包衣丸和/或相同组成的薄的游离薄膜的水摄取和溶胀动力学、机械性能和 TEC 的浸出。观察到以下异常趋势:(i)包衣丸的相对药物释放率随初始药物含量的增加而增加,(ii)与酒石酸美托洛尔相比,游离碱美托洛尔的药物释放速度要快得多,尽管其溶解度低得多(因子>70)。这些现象可以用药物对聚合物膜涂层的增塑作用来解释。特别是:1)游离碱美托洛尔是 Eudragit RS 比酒石酸美托洛尔更有效的增塑剂,导致更高的膜渗透性,并弥补了药物溶解度的明显差异。此外,拉曼成像显示,大量游离碱迁移到薄膜涂层中,而酒石酸盐则没有。2)当初始药物载药量从 10%增加到 40%时,药物对薄膜涂层的增塑作用过度补偿了潜在的溶解度增加的有限影响。总之,本研究清楚地表明,药物对聚合物控释薄膜涂层的增塑作用是多么重要,它会导致意想不到的配方效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验